Valuation: CellaVision AB

Market Cap 4.02B 406M 361M 334M 304M 574M 38.49B 583M 1.57B 20.09B 1.52B 1.49B 64.03B P/E 2026 *
28.9x
P/E 2027 * 22.4x
Enterprise Value 3.83B 386M 344M 318M 290M 547M 36.68B 555M 1.5B 19.14B 1.45B 1.42B 61.01B EV / Sales 2026 *
4.9x
EV / Sales 2027 * 4.31x
Free-Float
81.06%
Yield 2026 *
1.63%
Yield 2027 * 1.91%
1 day+1.08%
1 week+4.08%
Current month-2.77%
1 month+2.06%
3 months+14.40%
6 months+4.21%
Current year+7.12%
1 week 160.6
Extreme 160.6
168.4
1 month 160.6
Extreme 160.6
180.6
Current year 117.6
Extreme 117.6
180.6
1 year 117.6
Extreme 117.6
192.2
3 years 117.6
Extreme 117.6
302
5 years 117.6
Extreme 117.6
459
10 years 75.25
Extreme 75.25
503.5
Manager TitleAgeSince
Chief Executive Officer - 05/06/2026
Director of Finance/CFO 46 02/09/2025
Investor Relations Contact - -
Director TitleAgeSince
Director/Board Member 61 -
Director/Board Member 62 04/05/2018
Chairman 64 29/04/2021
Date Insider Type Main position Quantity % Market Cap. Importance
14/9/26 Buy

Chief Executive Officer

8,077 0.0339%
2/9/26 Free 100,000 0.4193%
28/4/26 Don

Founder

76,434 0.3205%
Change 5-day change 1-year change 3-year change Capi.($)
+1.08%+4.08%-6.44%+29.74% 406M
-0.93%+4.86%+28.03%+42.34% 255B
-1.06%+4.20%+9.56%+8.07% 161B
-0.27%+0.65%-4.36%+54.96% 151B
+0.57%+3.88%-55.27%-12.03% 64.33B
+1.47%+5.90%-13.25%-13.43% 51.9B
-0.85%+4.81%+9.39%+49.25% 50.25B
-1.70%+1.63%+16.02%+23.13% 49.92B
-1.47%+1.42%+21.88%+53.89% 48.77B
-1.62%+0.73%+30.59%+70.27% 42.93B
Average -0.48%+3.69%+3.62%+30.62% 87.54B
Weighted average by Cap. -0.69%+4.13%+8.50%+32.21%

Financials

2026 *2027 *
Net sales 782M 78.91M 70.15M 65.02M 59.15M 112M 7.49B 113M 306M 3.91B 296M 290M 12.46B 879M 88.75M 78.89M 73.12M 66.52M 126M 8.42B 128M 345M 4.4B 333M 326M 14.01B
Net income 139M 14.01M 12.45M 11.54M 10.5M 19.82M 1.33B 20.13M 54.39M 694M 52.57M 51.46M 2.21B 181M 18.32M 16.28M 15.09M 13.73M 25.91M 1.74B 26.33M 71.13M 907M 68.75M 67.28M 2.89B
Net Debt -189M -19.13M -17.01M -15.76M -14.34M -27.07M -1.82B -27.5M -74.3M -948M -71.81M -70.28M -3.02B -230M -23.22M -20.64M -19.13M -17.41M -32.85M -2.2B -33.38M -90.18M -1.15B -87.16M -85.3M -3.67B
Projected Income Statement - Annual - CellaVision AB
Logo CellaVision AB
CellaVision AB is a Sweden-based company active in the medical technology sector. The Company develops and sells digital solutions for medical microscopy, as well as products enabling blood cell analysis and morphology diagnosis. CellaVision AB’s product portfolio consists of analyzers for automated medical microscopy analysis and software applications designed for remote access, competency testing and education. The analyzers include such brands as CellaVision DM96 and CellaVision DM1200, whereas the software applications are divided into CellaVision Body Fluid Application, CellaVision Remote Review Software and CellaVision Competency Software, among others. The Company operates four subsidiaries, based in Sweden, Canada, the United States and Japan. In June 2014, CellaVision AB acquired technology platform from Clear Lake Medical Foundation.
Employees
251
Date Price Change Volume
16/10/26 SEK 168.40 +1.08% 24,153
15/10/26 SEK 166.60 +1.34% 44,466
14/10/26 SEK 164.40 -0.84% 74,794
13/10/26 SEK 165.80 +1.59% 24,006
12/10/26 SEK 163.20 +0.87% 17,677
Trader
Investor
Global
Quality
ESG MSCI
AAA
MarketScreener Ratings - CellaVision AB
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
3
Last Close Price
168.40SEK
Average target price
181.67SEK
Spread / Average Target
+7.88%

Quarterly revenue - Rate of surprise

Rate of surprise - Net sales - Quarterly - CellaVision AB
  1. Stock Market
  2. Stocks
  3. CEVI Stock